Brief: Sonnet Biotherapeutics Holdings Announces Stockholder Approval Of Proposed Business Combination With Hyperliquid Strategies
02/12/2025 14:18
Dec 2 (Reuters) - Sonnet Biotherapeutics Holdings Inc SONN.O: SONNET BIOTHERAPEUTICS HOLDINGS, INC. ANNOUNCES STOCKHOLDER APPROVAL OF PROPOSED BUSINESS COMBINATION WITH HYPERLIQUID STRATEGIES INC Source text: ID:nGNX5qTSQc Further company coverage: SONN.O ((Reuters.Briefs@thomsonreuters.com;))